Cargando…

Recurrent tuberculosis in Finland 1995–2013: a clinical and epidemiological cohort study

BACKGROUND: We investigated the epidemiology and prevalence of potential risk factors of tuberculosis (TB) recurrence in a population-based registry cohort of 8084 TB cases between 1995 and 2013. METHODS: An episode of recurrent TB was defined as a case re-registered in the National Infectious Disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Korhonen, Virve, Soini, Hanna, Vasankari, Tuula, Ollgren, Jukka, Smit, Pieter W., Ruutu, Petri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693478/
https://www.ncbi.nlm.nih.gov/pubmed/29145819
http://dx.doi.org/10.1186/s12879-017-2818-6
_version_ 1783279948046270464
author Korhonen, Virve
Soini, Hanna
Vasankari, Tuula
Ollgren, Jukka
Smit, Pieter W.
Ruutu, Petri
author_facet Korhonen, Virve
Soini, Hanna
Vasankari, Tuula
Ollgren, Jukka
Smit, Pieter W.
Ruutu, Petri
author_sort Korhonen, Virve
collection PubMed
description BACKGROUND: We investigated the epidemiology and prevalence of potential risk factors of tuberculosis (TB) recurrence in a population-based registry cohort of 8084 TB cases between 1995 and 2013. METHODS: An episode of recurrent TB was defined as a case re-registered in the National Infectious Disease Register at least 360 days from the date of the initial registration. A regression model was used to estimate risk factors for recurrence in the national cohort. To describe the presence of known risk factors for recurrence, patient records of the recurrent cases were reviewed for TB diagnosis confirmation, potential factors affecting the risk of recurrence, the treatment regimens given and the outcomes of the TB episodes preceding the recurrence. RESULTS: TB registry data included 84 patients, for whom more than 1 TB episode had been registered. After a careful clinical review, 50 recurrent TB cases (0.6%) were identified. The overall incidence of recurrence was 113 cases per 100,000 person-years over a median follow up of 6.1 years. For the first 2 years, the incidence of recurrence was over 200/100000. In multivariate analysis of the national cohort, younger age remained an independent risk factor at all time points, and male gender and pulmonary TB at 18 years of follow-up. Among the 50 recurrent cases, 35 patients (70%) had received adequate treatment for the first episode; in 12 cases (24%) the treating physician and in two cases (4%) the patient had discontinued treatment prematurely. In one case (2%) the treatment outcome could not be assessed. CONCLUSIONS: In Finland, the rate of recurrent TB was low despite no systematic directly observed therapy. The first 2 years after a TB episode had the highest risk for recurrence. Among the recurrent cases, the observed premature discontinuation of treatment in the first episode in nearly one fourth of the recurrent cases calls for improved training of the physicians.
format Online
Article
Text
id pubmed-5693478
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56934782017-11-24 Recurrent tuberculosis in Finland 1995–2013: a clinical and epidemiological cohort study Korhonen, Virve Soini, Hanna Vasankari, Tuula Ollgren, Jukka Smit, Pieter W. Ruutu, Petri BMC Infect Dis Research Article BACKGROUND: We investigated the epidemiology and prevalence of potential risk factors of tuberculosis (TB) recurrence in a population-based registry cohort of 8084 TB cases between 1995 and 2013. METHODS: An episode of recurrent TB was defined as a case re-registered in the National Infectious Disease Register at least 360 days from the date of the initial registration. A regression model was used to estimate risk factors for recurrence in the national cohort. To describe the presence of known risk factors for recurrence, patient records of the recurrent cases were reviewed for TB diagnosis confirmation, potential factors affecting the risk of recurrence, the treatment regimens given and the outcomes of the TB episodes preceding the recurrence. RESULTS: TB registry data included 84 patients, for whom more than 1 TB episode had been registered. After a careful clinical review, 50 recurrent TB cases (0.6%) were identified. The overall incidence of recurrence was 113 cases per 100,000 person-years over a median follow up of 6.1 years. For the first 2 years, the incidence of recurrence was over 200/100000. In multivariate analysis of the national cohort, younger age remained an independent risk factor at all time points, and male gender and pulmonary TB at 18 years of follow-up. Among the 50 recurrent cases, 35 patients (70%) had received adequate treatment for the first episode; in 12 cases (24%) the treating physician and in two cases (4%) the patient had discontinued treatment prematurely. In one case (2%) the treatment outcome could not be assessed. CONCLUSIONS: In Finland, the rate of recurrent TB was low despite no systematic directly observed therapy. The first 2 years after a TB episode had the highest risk for recurrence. Among the recurrent cases, the observed premature discontinuation of treatment in the first episode in nearly one fourth of the recurrent cases calls for improved training of the physicians. BioMed Central 2017-11-16 /pmc/articles/PMC5693478/ /pubmed/29145819 http://dx.doi.org/10.1186/s12879-017-2818-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Korhonen, Virve
Soini, Hanna
Vasankari, Tuula
Ollgren, Jukka
Smit, Pieter W.
Ruutu, Petri
Recurrent tuberculosis in Finland 1995–2013: a clinical and epidemiological cohort study
title Recurrent tuberculosis in Finland 1995–2013: a clinical and epidemiological cohort study
title_full Recurrent tuberculosis in Finland 1995–2013: a clinical and epidemiological cohort study
title_fullStr Recurrent tuberculosis in Finland 1995–2013: a clinical and epidemiological cohort study
title_full_unstemmed Recurrent tuberculosis in Finland 1995–2013: a clinical and epidemiological cohort study
title_short Recurrent tuberculosis in Finland 1995–2013: a clinical and epidemiological cohort study
title_sort recurrent tuberculosis in finland 1995–2013: a clinical and epidemiological cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693478/
https://www.ncbi.nlm.nih.gov/pubmed/29145819
http://dx.doi.org/10.1186/s12879-017-2818-6
work_keys_str_mv AT korhonenvirve recurrenttuberculosisinfinland19952013aclinicalandepidemiologicalcohortstudy
AT soinihanna recurrenttuberculosisinfinland19952013aclinicalandepidemiologicalcohortstudy
AT vasankarituula recurrenttuberculosisinfinland19952013aclinicalandepidemiologicalcohortstudy
AT ollgrenjukka recurrenttuberculosisinfinland19952013aclinicalandepidemiologicalcohortstudy
AT smitpieterw recurrenttuberculosisinfinland19952013aclinicalandepidemiologicalcohortstudy
AT ruutupetri recurrenttuberculosisinfinland19952013aclinicalandepidemiologicalcohortstudy